Researchers developed a vaccine based on the established rabies virus vaccine that, when tested in mice, proved safe and provided protection against both rabies and Ebola infection. Then they tested three different types of the novel rabies/Ebola vaccine in nonhuman primates to determine their protective effect. Read more about how the rabies vaccine protects nonhuman primates against the deadly Ebola virus.
Sequential Immunization With VSV-Based Lassa and Ebola Vaccines Does Not Diminish Protection in Monkeys, NIAID Study Finds
Researchers studying vesicular stomatitis virus (VSV) as a delivery system, or vector, for candidate vaccines against the hemorrhagic fever viruses Ebola, Marburg, and Lassa report full protection in study animals when using Lassa and Ebola vaccines in sequence. Read more about the NIAID study that found sequential immunization with VSV-based lassa and Ebola vaccines does not diminish protection in monkeys.